<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Canadian Pharmacy Blog &#187; Antibiotics</title>
	<atom:link href="http://annpharmacy.com/blog/category/antibiotics/feed" rel="self" type="application/rss+xml" />
	<link>http://annpharmacy.com/blog</link>
	<description>Health, Diseases, Drugs &#38; medications, Online canadian pharmacy</description>
	<lastBuildDate>Wed, 28 Jul 2010 16:32:20 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.1-beta1</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Generic Approvals Generic MetroGel for Vaginosis</title>
		<link>http://annpharmacy.com/blog/antibiotics/generic-approvals-generic-metrogel-for-vaginosis.html</link>
		<comments>http://annpharmacy.com/blog/antibiotics/generic-approvals-generic-metrogel-for-vaginosis.html#comments</comments>
		<pubDate>Wed, 21 Jul 2010 16:39:12 +0000</pubDate>
		<dc:creator>John Mitchell</dc:creator>
				<category><![CDATA[Antibiotics]]></category>
		<category><![CDATA[Generic Approvals]]></category>
		<category><![CDATA[Generic MetroGel]]></category>
		<category><![CDATA[Vaginosis]]></category>

		<guid isPermaLink="false">http://annpharmacy.com/blog/?p=446</guid>
		<description><![CDATA[
The Food and Drug Administration (FDA) has approved the first generic version of generic metronidazole vaginal gel (MetroGel, QLT USA), a treatment for bacterial vaginosis. This infection is characterized by vaginal discharge, and it results from an overgrowth of bacteria in the vagina.
]]></description>
		<wfw:commentRss>http://annpharmacy.com/blog/antibiotics/generic-approvals-generic-metrogel-for-vaginosis.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA Alert: Linezolid (Zyvox) And Gram-Negative Infections</title>
		<link>http://annpharmacy.com/blog/antibiotics/fda-alert-linezolid-zyvox-and-gram-negative-infections.html</link>
		<comments>http://annpharmacy.com/blog/antibiotics/fda-alert-linezolid-zyvox-and-gram-negative-infections.html#comments</comments>
		<pubDate>Wed, 23 Jun 2010 11:36:57 +0000</pubDate>
		<dc:creator>John Mitchell</dc:creator>
				<category><![CDATA[Antibiotics]]></category>
		<category><![CDATA[FDA Alert]]></category>
		<category><![CDATA[Linezolid]]></category>

		<guid isPermaLink="false">http://annpharmacy.com/blog/?p=376</guid>
		<description><![CDATA[
The FDA has alerted prescribers of new safety concerns about linezolid (Zyvox generic, Pfizer).
A recent open-label, randomized trial compared linezolid with vancomycin (Vancocin, Viro Pharma), oxacillin (Bactocill, SmithKlineBeecham; Prostaphlin, Apothecon), or dicloxacillin (Dycill, GlaxoSmithKline; Dynapen, Apothecon) in seriously ill patients with intravascular catheter-related bloodstream and catheter-site infections. Patients receiving linezolid had a higher chance of [...]]]></description>
		<wfw:commentRss>http://annpharmacy.com/blog/antibiotics/fda-alert-linezolid-zyvox-and-gram-negative-infections.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Retapamulin (Altabax) Ointment for Impetigo</title>
		<link>http://annpharmacy.com/blog/antibiotics/retapamulin-altabax-ointment-for-impetigo.html</link>
		<comments>http://annpharmacy.com/blog/antibiotics/retapamulin-altabax-ointment-for-impetigo.html#comments</comments>
		<pubDate>Fri, 14 May 2010 15:26:06 +0000</pubDate>
		<dc:creator>John Mitchell</dc:creator>
				<category><![CDATA[Antibiotics]]></category>
		<category><![CDATA[Altabax]]></category>
		<category><![CDATA[Ointment]]></category>
		<category><![CDATA[Retapamulin]]></category>

		<guid isPermaLink="false">http://annpharmacy.com/blog/?p=269</guid>
		<description><![CDATA[Retapamulin ointment (Altabax, Glaxo-SmithKline) has been approved for the topical treatment of impetigo caused by susceptible strains of Staphylococcus aureus or Streptococcus pyogenes, the two most common types of bacteria in this kind of infection.
Impetigo is considered a contagious infection of the skin&#8217;s top layers. It is most common among infants and children two to [...]]]></description>
		<wfw:commentRss>http://annpharmacy.com/blog/antibiotics/retapamulin-altabax-ointment-for-impetigo.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Omnicef the most effective medicine for ear infections</title>
		<link>http://annpharmacy.com/blog/antibiotics/omnicef-the-most-effective-medicine-for-ear-infections.html</link>
		<comments>http://annpharmacy.com/blog/antibiotics/omnicef-the-most-effective-medicine-for-ear-infections.html#comments</comments>
		<pubDate>Thu, 12 Nov 2009 20:29:32 +0000</pubDate>
		<dc:creator>John Mitchell</dc:creator>
				<category><![CDATA[Antibiotics]]></category>
		<category><![CDATA[antibiotic]]></category>
		<category><![CDATA[Augmentin]]></category>
		<category><![CDATA[cefdinir]]></category>
		<category><![CDATA[Omnicef]]></category>

		<guid isPermaLink="false">http://annpharmacy.com/blog/?p=65</guid>
		<description><![CDATA[This study presented at the International Society of  quality of Life demonstrated that children taking Omnicef drug were 28 percent more likely to finish all their medication than those taking Augmentin antibiotic. Parents regarded generic Omnicef a significantly effective, easier-to-use medicine in the antibiotic list to treat acute otitis media.
In this study, researchers compared [...]]]></description>
		<wfw:commentRss>http://annpharmacy.com/blog/antibiotics/omnicef-the-most-effective-medicine-for-ear-infections.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Omnicef Oral Antibiotic</title>
		<link>http://annpharmacy.com/blog/antibiotics/omnicef-oral-antibiotic.html</link>
		<comments>http://annpharmacy.com/blog/antibiotics/omnicef-oral-antibiotic.html#comments</comments>
		<pubDate>Sat, 24 Oct 2009 18:00:13 +0000</pubDate>
		<dc:creator>John Mitchell</dc:creator>
				<category><![CDATA[Antibiotics]]></category>
		<category><![CDATA[antibiotic]]></category>
		<category><![CDATA[cefdinir]]></category>
		<category><![CDATA[Omnicef]]></category>
		<category><![CDATA[penicillin]]></category>

		<guid isPermaLink="false">http://annpharmacy.com/blog/?p=60</guid>
		<description><![CDATA[Oral antibiotic  omnicef (cefdinir) is indicated for pediatric patients  (ages six months to 12 years) in the form of suspension to treat from mild to moderate  infections: acute bacterial otitis media, Haemophilus influenzae (including  beta-lactamase-producing strains), Streptococcus pneumoniae (penicillin-susceptible strains only)  and Moraxella catarrhalis (including beta-lactamase-producing strains); and  pharyngitis/tonsillitis [...]]]></description>
		<wfw:commentRss>http://annpharmacy.com/blog/antibiotics/omnicef-oral-antibiotic.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA approves new Omnicef (Cefdinir) oral suspension dosage for pediatric use</title>
		<link>http://annpharmacy.com/blog/antibiotics/fda-approves-new-omnicef-cefdinir-oral-suspension-dosage-for-pediatric-use.html</link>
		<comments>http://annpharmacy.com/blog/antibiotics/fda-approves-new-omnicef-cefdinir-oral-suspension-dosage-for-pediatric-use.html#comments</comments>
		<pubDate>Thu, 10 Sep 2009 09:52:32 +0000</pubDate>
		<dc:creator>John Mitchell</dc:creator>
				<category><![CDATA[Antibiotics]]></category>
		<category><![CDATA[antibiotic]]></category>
		<category><![CDATA[cefdinir]]></category>
		<category><![CDATA[medications]]></category>
		<category><![CDATA[Omnicef]]></category>

		<guid isPermaLink="false">http://annpharmacy.com/blog/?p=56</guid>
		<description><![CDATA[
Abbott  Laboratories announced today that a new FDA approved 250mg/5m dosing option of  the antibiotic Omnicef (generic cefdinir) Oral Suspension (OS) is  available for use in pediatric patients six months to 12 years old. The more  concentrated 250mg/5mL formulation allows parents to administer fewer teaspoons  per dose of the antibiotic [...]]]></description>
		<wfw:commentRss>http://annpharmacy.com/blog/antibiotics/fda-approves-new-omnicef-cefdinir-oral-suspension-dosage-for-pediatric-use.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
